Observational studyJournal of neurology2022

Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study.

Yao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.